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Abstract
Doublecortin (DCX) is widely regarded as a marker of immature and migrating neurons during development. While
DCX expression persists in adults, particularly in the temporal lobe and neurogenic regions, it is unknown how
seizures influence its expression. The aim of the present study was to explore the distribution and characteristics of
DCX-expressing cells in surgical and postmortem samples from 40 adult and paediatric patients, with epilepsy and with
or without hippocampal sclerosis (HS), compared to post mortem controls. The hippocampus (pes and body),
parahippocampal gyrus, amygdala, temporal pole and temporal cortex were examined with DCX immunohistochemistry
using four commercially-available DCX antibodies, labelled cells were quantified in different regions of interest as well as
their co-expression with cell type specific markers (CD68, Iba1, GFAP, GFAP∂, nestin, SOX2, CD34, OLIG2, PDGFRβ, NeuN)
and cell cycle marker (MCM2). Histological findings were compared with clinical data, as well as gene expression data
obtained from the temporal cortex of 83 temporal lobe epilepsy cases with HS. DCX immunohistochemistry identified
immature (Nestin−/NeuN−) neurons in layer II of the temporal neocortex in patients with and without epilepsy. Their
number declined significantly with age but was not associated with the presence of hippocampal sclerosis, seizure
semiology or memory dysfunction. DCX+ cells were prominent in the paralaminar nuclei and periamygdalar cortex and
these declined with age but were not significantly associated with epilepsy history. DCX expressing cells with ramified
processes were prominent in all regions, particularly in the hippocampal subgranular zone, where significantly increased
numbers were observed in epilepsy samples compared to controls. DCX ramified cells co-expressed Iba1, CD68 and
PDGFRβ, and less frequently MCM2, OLIG2 and SOX2, but no co-localization was observed with CD34, nestin or
GFAP/GFAP ∂. Gene expression data from neocortical samples in patients with TLE and HS supported ongoing
DCX expression in adults. We conclude that DCX identifies a range of morphological cell types in temporal lobe
epilepsy, including immature populations, glial and microglial cell types. Their clinical relevance and biological
function requires further study but we show some evidence for alteration with age and in epilepsy.
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Introduction
Doublecortin (DCX) is a microtubule-associated protein
critical for normal neuronal migration during develop-
ment. It has been widely used as a reliable marker to study
post-mitotic, immature neurons in the adult mammalian
brain [11, 14, 33, 37] as well as responses of these cell
types to brain insults [9, 25, 51]. There is anatomically
restricted expression in the normal mature mammalian
brain, with DCX+ multipolar and ‘tangled’ neurons re-
ported in cortical layer II, mainly in the temporal lobe, in
a variety of species [36, 49] and in the peri-amydgala
association cortex and amygdala [52]. The physiological
function of persisting DCX+ neurons is unknown: roles
in olfactory processing and memory have been postulated
[6]. DCX+ neurons remain relatively unexplored in
humans and their clinical significance is uncertain. DCX+
populations diminish with age in animals [6] but studies
have suggested seizure-enhanced maturation and prolifer-
ation of DCX+ cell types occurs in temporal lobe epilepsy
(TLE) [9, 28, 40] indicative of their underlying plasticity
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and responsiveness. In addition, reports have noted
DCX expression in non-neuronal cell types, including
in relation to cortical pathology and brain injury and
repair [25, 46].
The aim of this study was to further explore the morph-
ology, phenotype, distribution and density of DCX+ cells in
TLE. We included surgical samples from a wide age range
both with and without hippocampal sclerosis (HS), the
commonest pathology in TLE [4]. We compared this to
findings in post-mortem (PM) samples from patients with
epilepsy and HS and non-epilepsy controls to explore any
differences in the morphology and number of DCX + cells
between these groups. In addition we compared the neuro-
pathological findings to available gene-expression data
from a parallel study of the temporal lobe cortex from a
large series of TLE patients. Neuropathology findings were
also correlated with clinical epilepsy history, including type
of seizures, aura and any memory dysfunction, to explore
pathophysiological roles of these cell types.
Methods
Case selection
Fifty-two cases were included in the histological study
(Table 1). Adult temporal lobe epilepsy (TLE) cases from
patients undergoing elective surgery for the treatment of
refractory epilepsy (n = 19) were selected from the data-
bases of the Epilepsy Society Brain and Tissue Bank at
UCL Institute of Neurology and pediatric TLE surgical
cases (n = 5) were obtained from Great Ormond Street
Hospital NHS Trust. Adult post mortem (PM) tissue from
patients with (n = 16) or without (n = 12) epilepsy during
life (healthy controls) was obtained from the Epilepsy So-
ciety and MRC sudden death brain banks respectively;
none of these patients had undergone neurosurgical treat-
ments during life. The study has ethical approval and all
cases were consented for use in research (Ethics commit-
tee approval NRES17/SC/0573). In 18/24 surgical cases
and 8/16 of the epilepsy PM cases, hippocampal sclerosis
(HS) ILAE type 1 [5] was present. None of these cases had
additional temporal lobe sclerosis/cortical dysplasia [43]
or other lesion.
Tissue was examined from six regions of the temporal
lobe in the majority of adult surgical cases, including: (i)
temporal neocortex (superior temporal gyrus to fusiform
gyrus at 1 cm rostral to temporal pole) (Fig. 1a), (ii) tem-
poral pole, (iii) mid-hippocampus body, (iii) pes hippocam-
pus, (iv) parahippocampal gyrus (PHG) and (v) amygdala.
As a standard anterior temporal lobectomy procedure was
performed and a routine tissue handling and processing
protocol was followed, the regions selected were ana-
tomically comparable between cases. In surgical cases,
the amygdala tissue was typically fragmented which lim-
ited identification of all subnuclei. In PM cases, coronal
sections of the mid hippocampal body, adjacent temporal
cortex and/or sections through the entire mid to caudal
amygdala, including the paralaminar nuclei, were exam-
ined (Fig. 2a, Additional file 1: Table S1 for details).
Immunohistochemistry
Immunochemistry for DCX was carried out on 5 μm
thick formalin-fixed, paraffin-embedded sections. We trialed
four DCX commercially-available antibodies on selected
Table 1 Clinical and pathology details of cases and control groups (Further detail of each case is available in Additional file 1: Table S1)
Group Tissue type NUMBER Predominant pattern
of HS in body









Surgical Fixed 5 ILAE type 1 HS only 12.2 (8–15) 2F: 3 M HB, TLobe / q IHC
Adult epilepsy TLE/NO
HS (S19–24)
Surgical Fixed 6 NO HS 28.6 (24–35) 2F: 4 M HB,PES,PHG,TPole, TLobe,
Amyg / q IHC
Adult epilepsy (EPM1–16) Post Mortem 16 ILAE type 1 HS in 8
CASES
48.7 (18–75) 8F: 8 M HB, PHG, Amyg, Temporal
Cortex (Both hemispheres
included in 4 cases) / q IHC
Adult non-epilepsy
controls (C1–12)
Post mortem 12 No HS 56.4 (28–85) 5F: 7 M HB, PHG, Amyg, Temporal
Cortex / q IHC
Adult epilepsy TLE/HS Fresh 83
77a
All HS (16 with TLS)



















A1C, inferior and superior TC
S surgical epilepsy case, EPM adult epilepsy post-mortem, C Post-mortem control, HB Hippocampal body, PES pes hippocampus, PHG parahippocampal gyrus, TPole
temporal pole, TLobe temporal lobe, TLS temporal lobe sclerosis, Amyg amygdala, HS hippocampal sclerosis, qIHC qualitative and quantitative immunohistochemistry,
RNAseq RNA sequencing and expression analysis, ILAE International League against epilepsy, TLE temporal lobe epilepsy.
aOnly samples from adolescence and young and middle adulthood period. Controls from Kang et al.
bSamples obtained from the MRC brain bank, Edinburgh. A1C = Primary auditory cortex
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surgical and PM cases. All four antibodies were previously
validated in publications on human tissues [9, 28, 34, 40, 46]
(Table 2; DCX Ab1 to 4). All DCX antibodies showed
immunopositive labelling, but DCX Ab1 (clone 4604, Cell
signaling, Boston, USA) labelled a greater diversity of cell
types, and more intense labelling was observed in both sur-
gical and PM human brain tissues. Consequently, DCX Ab1
was used across all cases for the descriptive and quantitative
analysis. Double label immunofluorescent studies were per-
formed on all anatomical regions of five selected surgical
cases (Additional file 1: Table S1); combinations included
DCX Ab1 with different DCX antibodies, and DCX Ab1
with astroglial (GFAP, GFAP-∂), microglial (Iba1, HLA-DR,
CD68), mature neuronal (NeuN), immature/stem cells
Fig. 1 Doublecortin (DCX) in the cortex and hippocampus. a Section though a temporal lobe indicating the regions studies (MTG =middle temporal
gyrus, ITG, inferior temporal gyrus, FG = fusiform gyrus) b Layer II DCX positive cells (DCX+) using DCX Ab 4 (see Table 2). Cells of different size, including
some with more neuronal features and radial perpendicular processes (arrowhead) as well as dense nuclear labelling of small cells without processes
(arrow) were observed. C. A bipolar cell in cortical layer II with DCX labelling with long beaded processes extending perpendicularly into layer
I. d Clusters of small, intensely labelled DCX+ cells at interface of layer II and I labelled using DCX Ab1 (see Table 2). Top insert shows clusters
of DCX+ cells; the bottom insert shows prominent nucleoli and neuronal appearance of DCX+ cells. e In the hippocampus granule cell layer
(GCL) small DCX+ cells with ramified, multiple processes were observed; f In another case, the delicate branching processes of the ramified
cells are shown. g A column of DCX+ cells extending though the GCL was observed in another case. h Granule cell neurons showed occasional DCX
expression. i Small round DCX+ oligo-like cells were noted in the hippocampus in satellite location to neurons. j.DCX expression, in the periventricular
germinal matrix of the lateral ventricle, in a developmental human control of 13 weeks, showing small cells with extended processes. k Bar chart
showing greater linear densities for all morphological DCX+ cell types in surgical epilepsy cases compared to post mortem (PM) epilepsy controls and
controls with statistically significant differences noted for ramified cell types only (p < 0.0001). l The linear density of layer II tufted DCX+ cell types
showed an inverse correlation with age for all cases (surgical and PM) (p = 0.001) as well as for surgical cases alone (p = 0.016; not shown on
graph). m Although greater DCX+ linear densities of tufted cells were present in patients with sensory aura of abnormal taste and smell
compared to other aura types or no auras but these differences were not significant. Bar = 1 cm in A; B, D, F, G-J = 20 μm approx. (original
magnification × 400) and C and E = 50 μm approx
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(nestin, CD34, SOX2), oligodendroglia (OLIG2), NG2-cells
and pericytes (PDGFRβ) [11, 16] and cell cycle markers
(MCM2). Details of the immunostaining protocols are in-
cluded in Table 2 and the Additional file 2.
Quantitative and qualitative analysis
DCX-immuno-labelled cells (DCX+) at the boundaries of
cortical layer I/II in the temporal lobe of all cases were
quantified using Image pro plus (Media Cybernetics,
Cambridge, UK). Sequential images were captured at ×
40 using a Leica DBMR microscope along the entire
length of layer I and II from the gyrus to the sulcus of
the most inferior-mesial gyrus (fusiform gyrus (FG) or
inferior temporal gyrus (ITG))(Fig. 1a). DCX+ cells of
different morphologies were counted and expressed as
cells per mm of gyrus length. DCX+ cell types in other
anatomical regions were semi-quantified as: (0) absent,
(+) rare/occasional, (++) moderate numbers, (+++) many
cells. In PM cases where the entire coronal cross-section
of the paralaminar nucleus was present, the presence of
DCX+ cells was evaluated as: (0) absent, (+) single cluster,
(++) 2–3 clusters, and (+++) > 4 clusters. In the adjacent
peri-amygdala cortex (PAC; Fig. 2a) DCX in the superficial
cortex was assessed as: (+) occasional single DCX+ cell,
(++) several single cells or one cluster, (+++) 2–3 clus-
ters, (++++) > 4 clusters.
Qualitative examinations of double-labelled sections were
carried out with a Zeiss Axio Imager Z2, and confocal laser
scanning microscope (LSM-Meta 710, Zeiss, Göttingen,
Germany). The software, Zen 2012 blue lite version (Zeiss,
Göttingen, Germany), was used to view z-stacks of confocal
images, and to compose three-dimensional orthogonal
projections.
DCX mRNA analysis
Histology data was compared to DCX mRNA expression
analyses from 83 surgical TLE cases (Table 1); in 16 of
these cases there was evidence of temporal neocortical
sclerosis (layer II/III neuronal loss and gliosis) in addition
to hippocampal sclerosis [43]. TLE samples were obtained
from the UCL Epilepsy Society Brain and tissue bank and
compared to 73 PM non-epilepsy control tissues samples
from the MRC Sudden Death Brain and Tissue Bank
(Table 1). This data formed part of a separate study
(Matarin et al., in preparation). We also compared this
data to pre-existing expression array data; specifically
DCX mRNA expression in ten different brain regions of
non-epilepsy control cases including occipital, temporal,
frontal, hippocampus, putamen, thalamus, substantia nigra,
white matter, medulla and cerebellum as well as different
life periods from embryonic to late adulthood [21].
For temporal lobe cases (patients and controls), RNA
was isolated from the middle temporal gyrus (MTG)
cortex and samples were randomly placed and hybridized
to Affymetrix Exon 1.0 ST arrays as previously described
[22]. Control tissue from other brain regions and different
Fig. 2 Amygdala and DCX expression. a Coronal level though caudal amygdala in a post mortem case indicating the location of the paralaminar
nucleus with red arrows. PAC = peri-amygdala cortex, AB = accessory basal, B = basal and L = lateral nuclei. b DCX positive cells clusters and beaded
fibres in the PAC of a surgical patient with TLE/HS; c In a further case, columns of DCX+ cells were seen in the PAC as well as horizontal processes.
d Further surgical TLE/HS case with DCX Ab1 (see Table 2) with clusters of small immature cells with beaded processes and some with nuclear labelling
(inset: shows coarser DCX+ bundles traversing the amygdala in a surgical case). e Clusters of small densely labelled immature DCX+ cells and processes
in the amygdala in post mortem samples of paralaminar nucleus. f Post mortem caudal amygdala indicating the location of the paralaminar nucleus
above the ventricle. g The paralaminar nucleus shown at low magnification in DCX labelled section, with nests of positive cells and clusters of processes
indicated (arrows) running along the border. h At higher magnification these clusters correspond to small DCX+ cells intermingled with DCX
immunonegative-negative mature neurons. Bar in A, F = 800 μm approx.; G = 100 μm approx.; in B, C, E, H = 50 μm approx.; in D = 20 μm approx
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life periods were also originally analysed with Affymetrix
Exon 1.0 ST arrays [21] and data files were downloaded
from the NCBI Gene Expression Omnibus (accession
GSE25219 and GSE46706). Quality control analyses in-
cluded background correction, quantile normalization,
log2 transformation and median polishing probe-set
summarization. The effects of several methodological
and biological covariates were tested for significance and
was included in the linear regression or MANOVA models
when significant. All gene expression data was analyzed
with Affymetrix Power Tools software package and Partek
Genomics Suite (Partek Incorporated, St. Louis, MO, USA)
and R software.
Clinical data
The age of onset of seizures, age at surgery, seizure types,
laterality and outcomes at two years following surgery were
obtained from the clinical records of epilepsy patients
(Table 1 and Additional file 1: Table S1). Pre-operative
memory function tests were carried out as part of the
routine clinical assessment as previously described [44]
and detailed in Additional file 2: Methods. Data on
memory function was available in 15 adult surgical pa-
tients (Additional file 1: Table S1). Statistical analysis
was carried out between pathology and clinical groups
using non-parametric tests (including Kruskal-Wallis
with post-hoc corrections and Spearman correlation)
SPSS (IBM, California, version 22); p values of ≤0.05
were regarded as significant.
Results
Qualitative findings
DCX+ neuronal cell types
Neuronal-appearing unipolar (Fig. 1b), bipolar (Fig. 1c)
and multipolar DCX+ cells (Fig. 1d) were identified mainly
at the interface between layer I and II of the temporal
cortex as single cells or more rarely in clusters or rows
(Fig. 1d); they were observed in 18 of the 22 surgical
cases studied and henceforth are collectively referred to
as ‘layer II DCX+ cells’. The processes of multipolar tufted
cells extended mainly perpendicularly to the cortical sur-
face, projecting into layer I, where rarer horizontally-
orientated DCX+ cells and processes could be observed.
In all cases, layer II DCX+ cells intermingled with other
Table 2 Immunohistochemistry panel
Antibody Product code, Supplier Dilution (method) Target Epitope
DCX
Ab1
4606, Cell Signaling Tech. Boston, US. *Used in [28] 1:250 (IHC, IF) Amino acid sequence 40–70 and 350–410 of human DCX
DCX
Ab2
AB18723, Abcam, Cambridge, UK.
*Used in [34, 40]
1:4000 (IF) AA 300 to the C-terminus of synthetic human DCX
DCX
Ab3
SC-8066, Santa Cruz Biotech. Heidelberg, Germany.
*Used in [11, 24, 27]
1:400 (IF) C-terminus 365–402 of human DCX
DCX
Ab4
AB2253, EMD Millipore, Watford UK.
*Used in [45, 46]
1:1000 (IHC, IF) C-terminus 350–365
Nestin AB22035, Abcam, Cambridge, UK. 1:1000 (IHC, IF) 150 aa recombinant fragment from human nestin
conjugated to GST
Nestin AB105389, Abcam, Cambridge, UK. 1:100 (IF) Synthetic peptide corresponding to the C terminus of
Human Nestin.
Sox 2 AB5603, EMD Millipore, Hertfordshire, UK. 1:400 (IF) KLH-conjugated linear peptide corresponding to a
C-terminal region sequence of human Sox2
GFAP-∂ AB93251, Abcam, Cambridge, UK, 1:4000 (IF) Synthetic peptide conjugated to KLH derived from within
residues 350 to the C-terminus of Mouse GFAP ∂
GFAP Z0334, DAKO, Cambridgeshire, UK. 1:1500 (IF) GFAP
NeuN MAB377, EMD Millipore, Hertfordshire, UK. 1:100 (IF) Purified neuronal nuclei
Iba1 019–19,741, WAKO, Osaka, Japan. 1:6000 (IF) Synthetic peptide corresponding to C-terminus of Iba1
CD68 AB783, Abcam, Cambridge, UK. 1:50 (IF) Macrophages, microglia
CD34 IR632, DAKO, Cambridgeshire, UK. 1:25 (IF) Endothelial cells
Olig 2 AB9610, EMD Millipore Hertfordshire, UK 1:200 (IF) Recombinant mouse Olig-2
PDGFR-beta AB32570, Abcam, Cambridge, UK. 1:1000 (IF) Synthetic peptide within Human PDGF Receptor beta aa
1050 to the C-terminus
MCM2 610,700, BD biosciences, Oxford, UK. 1:900 (IF) Human BM28 aa. 725–888
For all antibodies, sections were pre-treated in sodium citrate solution (pH 6.0) microwaved at 800 W for twelve minutes. All primary antibodies were incubated
overnight at 4 °C, except for anti-Iba1, CD68 and GFAP which were incubated for an hour at room temperature, and anti-GFAP ∂ which was incubated for 48 h at
4 °C. *Previous studies using DCX in human tissue studies.
Abbreviations: IHC immunohistochemistry, IF immunofluorescence
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small, intensely labelled DCX+ cells without processes in
layer II (Fig. 1b) and occasionally with larger DCX+ cells
with more overt neuronal morphology (Fig. 1b). Layer II
DCX+ cells appeared more frequent along the ITG and
FG compared to MTG in surgical TLE cases. Layer II
DCX+ cells were also observed in the temporal pole of
over half of the cases studied, but less frequently in the
resected parahippocampal gyrus (PHG) and PM TLE and
control cases. Rare large DCX+ neuronal cells were noted
in the granule cell layer of the hippocampus in surgical
cases (Fig. 1h).
DCX+ glial cell types
Ramified DCX+ cells with multiple, branching processes
were visualized mainly with the DCX antibody DCX Ab1
(Fig. 1e). Ramified DCX+ cells were present in all regions of
all TLE cases, with and without HS, and all PM cases and
noted in the gray and white matter. In the hippocampus,
ramified DCX+ cells were particularly prominent in the
hilus and subgranular zone of the dentate gyrus, extending
through the granule cell layer. Occasional clusters or col-
umns of DCX+ cells were seen (Fig. 1g) and proximity to
CA1 pyramidal neurones. There were also present in the
pes hippocampus and PHG in all cortical layers and white
matter. Ramified cells were morphologically reminiscent of
microglia and NG2+ cells as well as immature migrating
neurons in the developing fetal brain in the periventricular
zone (Fig. 1j). Occasional cells were also noted alongside
vessels. In addition, a population of small round DCX+
oligo-like cells, without cytoplasmic processes, were scat-
tered in white matter and cortex, visualized with all DCX
antibodies; similar cells were often seen in a satellite
position adjacent to neurons (Fig. 1i), particularly in deep
cortical layers, as previously reported [40].
DCX+ cells in amygdala
Surgical cases The peri-amygdala cortex (PAC) and
paralaminar/periventricular nuclei could be anatomically
identified in surgical cases, but were incompletely repre-
sented. All DCX antibodies labelled clusters of small
DCX+ cells, mainly in the superficial cortex of the PAC
(Fig. 2b-d). These DCX+ cells were sometimes arranged
in horizontal or vertical columns, with beaded linear pro-
cesses (Fig. 2c). Fragments of amygdalar nuclei with a ven-
tricular border (paralaminar nuclei) showed aggregates of
small, intensely-labelled DCX+ cells and fibres inter-
mingled with DCX-negative, mature neurons. Coarse fibre
tracts and bundles of DCX+ processes were also occasion-
ally noted in the amygdala of all surgical cases (Fig. 2d,
inset). In addition, ramified DCX+ cells with cytoplasmic
labelling, as observed in other regions, were widespread.
PM cases: Variable labelling of small DCX+ cell aggre-
gates in the paralaminar nucleus of the amygdala was
noted, particularly along the ventricle wall in the caudal
amygdala (Fig. 2f, g). In these regions, clusters of small im-
mature DCX+ nuclei were intermingled with larger and
intermediate-sized DCX-negative neurones. (Fig. 2h).
Some DCX+ cells were associated with fine beaded bipolar
processes Fig. 2e). In the PAC, scattered small immature
DCX+ cells with processes were noted, occasionally in
clusters, mainly at the interface between layer I and II in
either horizontal or perpendicular arrangements, as in the
surgical cases.
Double labelling studies and comparison of different DCX
antibody labelling
DCX antibodies DCX Ab1 showed the most extensive
labelling of cells and processes in different regions but
co-localization was confirmed in a proportion of small
cells with the three other different DCX antibodies
(Table 2, Fig. 3a). Temporal neocortex: In layer II of
the temporal lobe, DCX+ tufted cells showed only rare
co-localisation with mature neuronal marker NeuN
(Fig. 3b, c). There was no cellular co-expression of DCX
with mature glial marker GFAP, immature stem cell markers
nestin or GFAP∂, which both showed labelling of the
sub-pial band of astrocytes (Fig. 3e). There were a few
DCX+/Sox2+ cells noted. There were no CD34+ neuro-
glial cells in any of the surgical epilepsy cases. A minor
proportion of small oligo-like DCX+ cells in the white
matter co-expressed OLIG2 (Fig. 3d); in contrast, MCM2/
DCX+ cells were not observed (Fig. 3d inset). There
was extensive co-localisation between ramified DCX+
cells and Iba1, CD68 and, to a lesser extent, PDGFRβ.
Hippocampus body and pes: Very rare DCX+/NeuN+
cells were observed in the granule cell layer (Fig. 3f ).
We did not observe any co-expression between GFAP,
GFAP∂ and nestin with DCX and these markers
highlighted distinct cell populations in all regions (Fig. 3g).
There was, however, prominent co-localization of ramified,
multipolar DCX+ cells with Iba1 (Fig. 3h) and CD68
(Fig. 3i), particularly in the granule cell layer region. In
addition, co-expression of DCX with PDGFRβ was evi-
dent in some small branching cells as well as MCM2
(Fig. 3j). Occasional double-labelling of small oligo-like
cells with DCX and OLIG2 as well as SOX2 was noted
in hippocampal regions but not with CD34. Amygdala:
Although DCX+ and nestin-expressing cells were ob-
served in similar anatomical regions, particularly in the
paralaminar nucleus, they highlighted distinct cell pop-
ulations and processes (Fig. 3k, l). Multipolar, ramified
DCX+ cells showed co-expression with Iba1 (Fig. 3m)
and occasionally with PDGFRβ (Fig. 3n), but only in a
proportion of cells. Cellular co-expression of DCX with
NeuN, CD34, GFAP or MCM2 (fig. 3o) was not observed
in the amygdala of the cases examined and there was rare
co-expression of DCX with OLIG2 or SOX2.
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Quantitative analysis
Based on the above findings our hypothesis was that
quantitative analysis would confirm greater densities in
the number of DCX+ cells in epilepsy than control groups.
In the temporal lobe we confirmed higher linear densities
for all morphological DCX+ cell types in surgical epilepsy
cases compared to PM epilepsy cases and non-epilepsy
controls (Fig. 1k) with statistically significant differences
noted for ramified DCX+ cell populations (p < 0.0001).
We also investigated their relationship with patient age
and cortical region. The linear density of layer II cells
compared to other DCX+ cell types showed an inverse
correlation with age for all cases (surgical and PM) (p =
0.001) (Fig. 1l) as well as for surgical cases alone (p = 0.016)
and for age of seizure onset (p = 0.035). There were signifi-
cantly higher linear densities of tufted DCX+ cells in the
FG compared to the ITG (p = 0.004) but not for other
DCX+ cells types. We also hypothesized if there was a rela-
tionship between DCX+ linear densities and the presence
of HS but did not confirm this. Similarly, we considered if
DCX cell densities related to clinical parameters; there was
no significant difference in DCX+ cells in relation to seiz-
ure types (focal or generalized seizures), history of aura
(Fig. 1m) or if patients were seizure free (or not) two years
Fig. 3 Characterizing DCX positive cells in the temporal cortex, hippocampus and amygdala of surgical patients with epilepsy, and comparison of
commercial antibodies. In all panels, the arrowheads indicate single labelled cells, while arrows point to double labelled cells. Confocal images are
merged projections of 5 to 7 images acquired in a z-stack. a. The immunoreactivity of two different commercially-available anti-Dcx antibodies.
Both DCX Ab2 AB18723 (Abcam, Cambridgeshire, UK) and DCX Ab 1 #4606 (Cell Signaling Technology, Inc. MA, USA) labelled small cells in the
hippocampal granule cell layer (GCL) of a patient with epilepsy and HS Type 1 (arrow) (Table 2). DCX Ab1 labelled more cells overall than DCX
Ab2. DCX+ positive cells in the remaining figures were labelled using DCX Ab1. Temporal Cortex Layer I/II: b. NeuN expression was not
frequently observed in small DCX+ cells located in layer II of the temporal lobe cortex (arrowhead). c. In another case, DCX/NeuN positive cells
were more frequently observed in the superficial temporal cortex than in the temporal pole (arrows). d. DCX positive cells expressing Olig2 in the
nucleus (arrow) were noted in layer 1 of an epilepsy case (arrow), but MCM2/DCX+ cells were not observed (inset). e. Nestin+ glial fibres were
observed in the subpial layer and layer I and II, but did not co-localise with DCX expression. Hippocampus: f. In general there were rare DCX/NeuN
colocalised cells in the dentate gyrus; in this image there is a rare co-localised cell (arrow). g. GFAP showed dense labelling of astroglial process in
hippocampal regions but no co-localisation with DCX was noted. h. Labelling with Iba1 highlighted mature microglial cell types, with ramified processes,
particularly in the subgranular zone as shown, and many co-expressed DCX (arrow); i Co-labelled CD68/DCX+ cells were also observed
(arrow). j. PDGFRβ was expressed in multipolar cells in the hippocampus and temporal lobe in addition to pericytes; focal co-labelling with
DCX was noted in some cells (arrow); Inset show a DCX+ ramified cell expressing MCM2 in the nucleus. Amygdala. k. Distinct populations or
clusters of nestin+ or DCX+ cells in the amygdala periventricular nuclei; l. In another area, nests of DCX+ processes were also distinct from
nestin-expressing cells. m. In the amygdala, although DCX+ processes were largely Iba1 negative, Iba1/DCX+ ramified DCX+ cells were observed
(arrow). n. PDGFRβ and DCX in the amygdala showing distinct populations of small cells. o. DCX in the amygdala were mainly MCM2 negative. Bar is
equivalent to 20 μm. Individual channels for immunofluorescence images are shown in Additional file 4: Figure S2
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following surgery. We noted an association for increased
ramified DCX+ in cortical layer II in patients with severe
verbal pre-operative memory deficit (Additional file 3:
Figure S1; p = 0.027). In other regions (hippocampus,
pes hippocampus, PHG and temporal pole and
amygdala), semi-quantitative analysis of DCX+ rami-
fied and small cell types in surgical cases did not show
any significant differences between cases with HS or with-
out HS, relationship to age at surgery, age of seizure onset,
seizure types or outcome at 2 years. In PM cases, there
were no significant differences in DCX populations in
amygdala and PAC between epilepsy controls and con-
trols; there was a negative correlation between DCX+ cells
in the PAC and age over all PM cases (p = 0.04).
mRNA expression
From published data [21] DCX mRNA was expressed in
all brain regions tested and exhibited temporal and re-
gional significant differential expression (False Discovery
Rate 5%). There was higher DCX mRNA expression in
temporal, frontal and occipital regions and lower in cere-
bellum. DCX expression in the temporal cortex was higher
in periods before and early birth (embryonic, fetal and early
infancy) than in periods following the early infancy (late in-
fancy, childhood, adolescence and adulthood) (Fig. 4a). We
observed no significant differences in DCX expression in
the temporal cortex between left and right hemispheres in
controls [21] or TLE patients (adolescence and young and
middle adulthood periods) (Fig. 4b). We did not find sig-
nificant differences between patients with and without
temporal lobe sclerosis and neither between patients with
epilepsy and the 2 PM control groups (Fig. 4c) (For all
p values > 0.05 and fold change < 1.2).
Discussion
DCX is currently widely used as developmental marker
for post-mitotic, immature neurons in the brain and for
persistent neurogenesis in adulthood [14, 37]. Our study
highlights the varied morphologies of DCX+ cells in adult
TLE with ongoing expression supported by a parallel gene
expression study. Tangled DCX+ cells in layer II of the
temporal cortex did not express nestin, NeuN or MCM2,
declined in numbers with age and did not significantly
associate with clinical seizure semiology, memory dys-
function or the presence of HS. Amygdala DCX+ im-
mature neuronal populations were primarily located in
the paralaminar nucleus, but their number and morph-
ology were not different between cases and controls. We
also identified a subset of ramified and small cells with
DCX antibodies, representing a range of glial cell types
and supporting non-neuronal DCX expression; these were
increased in number in the neocortex in epilepsy, associ-
ated with memory impairment and may represent reactive
populations.
Temporal cortical DCX+ cells in epilepsy
The presence of persistent, immature, DCX+ neocortical
cells in layer II, primarily in the temporal lobe and piri-
form cortex, has been recognized in a range of adult
mammalian species since 2001 (reviewed in [6]). They
are less studied in humans and their precise physiological
function remains elusive. They have been variable termed
‘tangled and tufted’ cells or ‘semilunar/transitional’ neu-
rons, co-express PSA-NCAM or other immature neuronal
markers but reported to be mainly negative with mature
neuronal marker NeuN. Although the number of DCX+
cortical cells decline with age, they are considered to
endow the cortex with enhanced synaptic plasticity [23]
and roles in olfactory learning and memory have been
postulated [6]. In mammals they are not considered to be
newly generated in adulthood, but to arise during develop-
ment from migrating cells of the lateral cortical stream
[2]. A persistent temporal lobe migratory stream has also
been recently described in adult mammals, extending
from the temporal pole of the lateral ventricle to the piri-
form cortex and amygdala [14] and we have also recently
reported evidence for vestiges of a similar migratory
stream in the human adult mesial temporal lobe [27]. In
TLE an increased plexus of PSA-NCAM-positive neurons
was reported in layer II of the entorhinal cortex [30] and
increased DCX+ cells were noted in the temporal neo-
cortex in epilepsy compared to controls with evidence
for some maturation with NeuN expression, yet main-
taining a persistent immature phenotype (98% co-expressing
PSA-NCAM and 82% Tuj1) [28]. Similar tangled DCX+
cells in layer II were also prominent in young patients with
FCD type Ia [40].
In the current series, layer II DCX+ temporal neocor-
tical cells showed infrequent NeuN expression, in keeping
with some previous studies [15, 40]; the additional lack of
expression of the stem cell marker nestin could support
their intermediate differentiation between progenitor cells
and mature neurons [27]. We confirmed their anatomical
distribution, with increased density in more mesial tem-
poral neocortex, as suggested in previous reports [6, 28].
They were not prominent in the parahippocampal gyrus
cortex however and we also observed a significant decline
in the number of tangled cells with age. In our recent
study of TLE/HS patients aged over 50 years with early
Alzheimer-like pathology in temporal lobe resections, we
reported a lack of tau accumulation in layer II DCX+ cells,
suggesting their resistance to age-related neurodegenera-
tion [42], as also supported by experimental models [52].
We have shown in this study that the number of tangled
neurons is not increased in epilepsy patients compared to
controls, nor is the number related to clinical olfactory/
sensory auras, memory dysfunction the presence of hippo-
campal sclerosis or post-surgical outcome. In a parallel
gene expression study from patients with TLE/HS there
Liu et al. Acta Neuropathologica Communications  (2018) 6:60 Page 8 of 13
were no significant differences in patients with additional
temporal lobe superficial cortical neuronal loss and gliosis
(also called temporal lobe sclerosis) [43] from those with
normal/preserved neocortex. These findings could suggest
that layer II DCX+ cell types are unlikely to be clinical or
pathologically relevant to functional and acquired patholo-
gies in temporal lobe epilepsy.
Amygdala and DCX+ populations
The amygdala can initiate seizures in TLE and volume
changes, including enlargement are recognized in TLE
in addition to gliosis [3]. During development, migrating
DCX+ cells in the lateral cortical stream give rise to
neuronal and glial populations in the amygdala [2]; per-
sisting DCX+ cells in adulthood have been reported in
the primate amygdala and PAC, forming chains of cells,
a proportion of which co-express NeuN, their number
declining with age [52]. Similar cell types were also
confirmed in the human amygdala [29], in particular
the paralaminar nucleus of the amygdala, where abun-
dant rests of immature DCX+ neurons were shown in
one study [10]. The paralaminar nucleus, which sits along
the ventricle wall, is composed of nodules of small primi-
tive appearing cells, and is interconnected with other
amygdala nuclei receiving high serotonergic input. Its pre-
cise functions are uncertain [10]. In the current study,
DCX+ immature cells, primarily in the paralaminar nu-
cleus and PAC, were confirmed to exist in the amyg-
dala, in both surgical tissue as well as PM cases.
Diminished populations were associated with increasing
age but the cells did not show atypical morphology or al-
tered numbers in epilepsy or associate with the presence
Fig. 4 DCX mRNA expression data. a Significant DCX temporally differential expression between periods on temporal cortex (p value: 4.5e-113)
[21]. Periods 1: Embryonic, 2: Early Fetal, 3: Early midfetal 4: Late midfetal- 5 Late fetal 6 Neonatal and early Infancy 7 Late infancy 8 Early childhood 9
Middle and Late adulthood 10:Adolescence 11: Young adulthood 12: Middle adulthood 13: Late adulthood b DCX expression on right (R) and left (L)
temporal cortex on patients with temporal lobe epilepsy (TLE) [22] and controls [21] after correcting for batch differences. Periods 10, 11 and 12 c)
DCX mRNA expression data from 83 TLE (divided into cases with or without temporal lobe sclerosis (TS) (neuronal loss from the superficial
neocortex in addition to hippocampal sclerosis [43]) and controls from the MRC brain bank, Edinburgh, after correcting for batch, age, gender
and RIN differences. Periods 10 to 13
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of hippocampal sclerosis. Nevertheless, application of
DCX+ may be helpful in clinical practice to enable their
anatomical identification and avoid over-interpretation
as small malformations or hamartias, described in sur-
gical resections in TLE [17].
DCX – A reliable marker of neurogenesis in the mature
human brain?
There is increasing awareness of DCX expression in
non-neuronal cells types. DCX-expressing astroglial cells
have been noted in adult post mortem tissues in patients
with epilepsy and controls [46], in balloon cells in FCD
IIB and multipolar astroglial like cells in temporal lobe
sclerosis [40]. DCX+ stellate cells have been reported in
the vicinity of acute infarcts with co-expression of astro-
glial lineage markers (GFAP, S100) rather than microglial
or mature neuronal markers as NeuN [25]. In another
study however, DCX+ ‘rod’ cells in the infant hippocampal
subgranular zone region, that morphologically resembled
microglia, lacked CD68 and HLADR expression and were
argued to represent neural progenitor cell types [34]. In
adult mammals, DCX+ cells are reported to be enriched
in the subgranular zone of the hippocampus, and are
described as ‘ramified’, although exhibiting more overt
neuronal morphology with apical dendrites [14, 36]. Ex-
perimental tracing studies of DCX+ cell fate during
temporal lobe development show that 95% give rise to
TBR1-positive pyramidal neurons but a small proportion
differentiate to GFAP astrocytes (3.4%) and a further
population of small bipolar cells with sparsely branch-
ing processes are of uncertain lineage (1.7%) [2]. Single
cell transcriptomics of isolated DCX+ populations has
also provided evidence of cell subsets enriched for di-
vergent pathways, including astrocytic and myelinating
oligodendroglial fates [15]. Identification of DCX ex-
pression in oligodendroglial precursor cells (OPC) was
proposed to reflect cell migration rather than neuronal
differentiation [7] and DCX expression is also specu-
lated to have a role in glioblastoma infiltration [1].
Our current study adds further support to DCX expres-
sion in non-neuronal cell types. We noted frequent rami-
fied, multipolar DCX+ cells and oligo-like cells without
processes in many regions, including the SGZ, and these
were significantly increased in surgical TLE compared to
controls. These were observed mainly with one DCX
antibody although overlap of expression was noted in a
proportion of small cells with other commercial DCX
antibodies, suggesting different sensitivities. Although
DCX+ ramified cells in the dentate gyrus resembled cells
in the developing human sub-ventricular zone, they lacked
the typical unipolar or bipolar morphology [36]. Fur-
thermore, we confirmed that a proportion of ramified
DCX+ cells co-expressed microglial markers, as well as
PDGFRβ, supporting non-neuronal lineages. Significantly
more ramified DCX+ cells were noted in surgical epilepsy
cases in the temporal cortex compared to controls. How-
ever there were no differences between epilepsy cases with
or without hippocampal sclerosis. These different observa-
tions suggest enhanced DCX expression in reactive glial
cells types in epilepsy could be independent of underlying
pathology.
The observation of DCX in microglia was an unexpected
finding. Microglial cells are dynamic, motile cells which
show changes in morphology in response to brain activity
and injury, with increasingly recognized diverse and com-
plex roles [8, 32] including neurodevelopment as well as
epilepsy [13]. Understanding of these cells has advanced
with proteomic and transcriptomic analysis of isolated
microglia, aiming to identify specific proteins more abun-
dantly expressed, as candidate lineage and activation
markers [12, 38, 48, 53] (see https://omictools.com/glia-
open-access-database-tool). Although proteomics and gene
expression studies have suggested that DCX is not expressed
in microglia at significant levels [18–20, 38, 50, 53], differen-
tial gene expression studies do show DCX is dependent on
their activation state. For example, one study using laser sin-
gle cell capture and gene expression of microglial cell types
of different morphology showed that DCX was highly
enriched in activated amoeboid microglia and confirmed by
immunohistochemistry and PCR of a murine microglial cell
line [35]. Recent studies have also highlighted expression of
putative immature neuronal markers in reactive cell types,
including microglia in human slice cultures [47].
Intriguingly we also noted PDGFRβ+ co-expression in
some of the ramified DCX+ cells in TLE tissues; DCX
expression has been previously shown in pericytes [53].
Although PDGFRβ+ is widely recognized as a CNS peri-
cyte marker [41] it is also expressed in OPC/NG2 par-
enchymal glial cell types, which are reactive to seizures
[16, 26, 31, 39]. We also noted occasional DCX+ small
cells to co-express OLIG2 in keeping with reported low
DCX expression in OPC lineages [7, 53]. In our parallel
gene expression study from TLE cortex, DCX expression
was confirmed in adult temporal cortex and, although ex-
pression was not significantly increased in TLE compared
to controls, more detailed single cell analysis is warranted
to further investigate differential cellular expression in
epilepsy. Our findings therefore support ongoing DCX
expression in adults; expression in non-neuronal cells,
particularly in adults undergoing surgery for refractory
epilepsy, may suggest aberrant upregulation under patho-
logical conditions, including seizures.
Study limitations
There are several limitations to the study. The ages in the
epilepsy and control groups for the histology were not
precisely matched as in the mRNA study and although
ramified DCX+ cell densities did not show a relationship
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with age, we cannot exclude that this may have had an
effect. The PM cases with epilepsy and HS did not all
have syndromic TLE and limited memory tests were avail-
able. The gene expression data on MTG was obtained on
homogenized cortex from all cases rather than micro dis-
sected cortical layers or cells and was not carried out on
the ITG or FG where greater numbers of DCX+ cells are
observed. We did not have complete representation of the
FG in the surgical specimens, compared to the PM cases
in the analysis of Layer II DCX+ cells and in the amygdala
surgical specimens were fragmentation which limits
analysis of the entire nucleus.
Conclusions
DCX identifies a range of morphological cell types in
temporal lobe epilepsy, including immature populations
in the superficial cortex and amygdala that decline with
age but may not be specifically relevant to the epilepsy
or local pathology. We observed DCX+ reactive glial cell
types, including microglial lineages with some evidence
for increased numbers in epilepsy tissue. This suggests
that DCX not only is expressed in residual immature
neuronal cell types, but may have a role in brain responses
to seizure injury.
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B. There was no association between the number of tufted DCX+ neuronal
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